511 Pill - yellow round
Pill with imprint 511 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 511
Letrozole
- Imprint
- 511
- Strength
- 2.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 62756-0511 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
corn starch,
povidone k30,
sodium starch glycolate type A potato,
silicon dioxide,
magnesium stearate,
hypromelloses,
ferric oxide yellow,
titanium dioxide,
polyethylene glycol,
magnesium silicate
Note: Inactive ingredients may vary.
Related images for "511"
More about letrozole
Check interactions
Compare alternatives
Pricing & coupons
Reviews (336)
Drug images
Side effects
Dosage information
Patient tips
Patient resources
- Drug Information
- Letrozole (Advanced Reading)
- During pregnancy
- Support group
- Breastfeeding
- En español
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
